Target intelligence / Profile preview

Linker for activation of T cells family member 2 (LAT2)

Target
LAT2
Molecular classification
Amino acid transporter (specifically, L-type amino acid transporter, SLC7A8), Transmembrane adaptor/scaffolding protein (NTAL/LAB/LAT2), Other
01

Overview

Linker for activation of T cells family member 2 (LAT2), also known as SLC7A8, LAB, NTAL, and other aliases, refers primarily to two distinct biological entities based on context: (1) an amino acid transporter protein of the solute carrier family 7 member 8 (SLC7A8), functioning as a heterodimer with 4F2hc (SLC3A2) and mediating the transport of neutral amino acids and thyroid hormones across cell membranes, and (2) a transmembrane adaptor protein (also called NTAL/LAB) involved in immune cell signaling, particularly within B cells, mast cells, and other hematopoietic lineages[1][3][5][7]. As a transporter, LAT2 is essential for nutrient exchange, homeostasis, and metabolic processes in multiple tissues, and dysfunction or altered expression has been linked to cancer metabolism and microvascular protection in diabetic retinopathy[2][3][4][6]. As an adaptor/scaffolding protein, LAT2 participates in the assembly of signal transduction complexes after receptor activation, modulating both adaptive and innate immune responses and tempering high-affinity IgE (FcεRI)-mediated reactions[5][7]. **Important note:** The term "LAT2" can refer to: - SLC7A8 (an amino acid transporter, also known as L-type amino acid transporter 2) - A transmembrane adaptor protein (NTAL/LAB, official gene symbol: LAT2) These are discrete, unrelated proteins with non-overlapping gene loci and distinct functions: the amino acid transporter is not related (structurally or genetically) to NTAL/LAB, despite the overlapping abbreviation[1][3][5][7].

Other names
Linker for activation of B cellsNon-T cell activation linkerNTALLABWilliams-Beuren syndrome chromosomal region 15 protein (WBSCR15)Williams-Beuren syndrome chromosomal region 5 protein (WBSCR5)HSPC046Membrane-associated adapter moleculeWSCR5
02

Mechanism of action

Amino acid transport inhibition (e.g., LAT inhibitor reduces CD47 expression by inhibiting amino acid uptake); Indirect immune modulation (potential immunomodulation via amino acid availability/signaling complex assembly)

03

Biological functions

Amino acid transport, including neutral amino acids and thyroid hormonesSignal transduction modulation in immune cells, such as B cells and mast cells (adaptor/scaffolding protein)Immune regulationCell metabolismRegulation of downstream signaling pathways (e.g., MAP kinase activation, calcium mobilization)Modulation of receptor-mediated cellular responses
04

Disease associations

Cancer (implicated in cancer cell growth/metabolism)Diabetic retinopathy (protective role in microvascular complications)Immune/inflammatory diseases (immune cell signaling, mast cell activation)Other
05

Safety considerations

Therapeutic targeting is limited by the wide expression and essential amino acid transport function, raising concerns for metabolic disruption if inhibited systemicallyNo selective or approved small molecule inhibitors/substrates for clinical inhibition exist
06

Interacting drugs

2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH, a broad LAT inhibitor that can target LAT2 function in some studies)

1 more in the full profile.

07

Biomarkers

LAT2 plasma levels (biomarker for reduced risk/protective effect in diabetic retinopathy)

Beyond the preview

Go deeper on Linker for activation of T cells family member 2 (LAT2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Linker for activation of T cells family member 2 (LAT2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call